News of Note—J&J launches neurovascular business; Olympus to pay $6.6M over superbug outbreak

news of note

> Johnson & Johnson unveiled a new neurovascular business, dubbed Cerenovus, which includes products that the conglomerate's Codman Neuro unit picked up in its acquisitions of Pulsar Vascular and stroke care company Neuravi. Release

> A jury ordered endoscope maker Olympus to fork over $6.6 million in damages to a Seattle hospital. The verdict concludes an eight-week trial surrounding the company's endoscopes and drug-resistant infections. MedCityNews story | Read more

> Roxwood Medical has struck a deal with Abbott to distribute its cardiovascular catheters in the U.S. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.